{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:01:48Z","timestamp":1769522508136,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>IgA nephropathy (IgAN) is the most common disorder in chronic glomerulonephritis, and various treatment methods have been established. Tonsillectomy and steroid pulse therapy (TSP) are widely performed in Japan. However, their correlation with renal outcomes remains unclear. In this study, we aimed to examine the association between renal prognosis and steroid pulse therapy with or without tonsillectomy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this retrospective cohort study, we identified patients diagnosed with IgAN between April 2002 and March 2021 using a Japanese healthcare records database. We selected patients with a prescription history of methylprednisolone for three consecutive days within one year of diagnosis and an estimated glomerular filtration rate (eGFR) of 30\u00a0mL\/min\/1.73\u00a0m<jats:sup>2<\/jats:sup> or above. We categorized the patients into TSP and steroid pulse therapy (SP) groups based on whether they underwent tonsillectomy within one year of diagnosis. The primary outcome was the composite outcome of a 30% decline in eGFR and initiation of dialysis, and the secondary outcomes comprised the composite outcome of end-stage renal failure and initiation of dialysis and eGFR slope. Inverse probability of treatment weighting (IPTW) using propensity score, Kaplan\u2013Meier survival analysis, and weighted Cox regression analysis by applying IPTW were performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Overall, 550 patients were eligible for the main analysis, and approximately 40% underwent tonsillectomy within 1\u00a0year of IgAN diagnosis: 221 in the TSP group and 329 in the SP group. The primary outcome did not differ between the groups (hazard ratio, 0.58; [95% confidence interval: 0.22\u20131.54]; P\u2009=\u20090.28). The groups did not differ in terms of the secondary outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Although we could not demonstrate the effectiveness of TSP on renal prognosis in patients with IgAN, this study may have been underpowered, and there are certain limitations due to the information available from the database, we were able to evaluate the association of TSP on renal outcomes using real-world data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical Trial Number<\/jats:title>\n            <jats:p>Not applicable.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12882-025-04408-5","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T10:34:54Z","timestamp":1755945294000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between tonsillectomy plus steroid pulse therapy and renal outcomes in patients with IgA nephropathy: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Ayano","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayoko","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanna","family":"Shinkawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Sakoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satomi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoko","family":"Yanagita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7477-4071","authenticated-orcid":false,"given":"Koji","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,23]]},"reference":[{"key":"4408_CR1","doi-asserted-by":"crossref","unstructured":"Habas E, Ali E, Farfar K, Errayes M, Alfitori J, Habas E, Ghazouani H, Akbar R, Khan F, Al Dab A, et al. IgA nephropathy pathogenesis and therapy: review & updates. Medicine (Baltimore). 2022;101(48).","DOI":"10.1097\/MD.0000000000031219"},{"issue":"4","key":"4408_CR2","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S0272-6386(97)90333-4","volume":"29","author":"A Koyama","year":"1997","unstructured":"Koyama A, Igarashi M, Kobayashi M. Natural history and risk factors for immunoglobulin A nephropathy in Japan. research group on progressive renal diseases. Am J Kidney Dis. 1997;29(4):526\u201332.","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"4408_CR3","first-page":"473","volume":"56","author":"N Hanafusa","year":"2022","unstructured":"Hanafusa N, Abe M, Jyouki N, Hoshino J. Annual dialysis data report, JSDT renal data registry. J Jpn Soc Dial Ther 2023. 2022;56(12):473\u2013536.","journal-title":"J Jpn Soc Dial Ther 2023"},{"issue":"4","key":"4408_CR4","doi-asserted-by":"publisher","first-page":"677","DOI":"10.2215\/CJN.07420716","volume":"12","author":"JC Rodrigues","year":"2017","unstructured":"Rodrigues JC, Haas M, Reich HN. IgA Nephropathy. Clin J Am Soc Nephrol. 2017;12(4):677\u201386.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"4408_CR5","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1093\/ndt\/gfad146","volume":"38","author":"PJ Gleeson","year":"2023","unstructured":"Gleeson PJ, O\u2019Shaughnessy MM, Barratt J. IgA nephropathy in adults-treatment standard. Nephrol Dial Transplant. 2023;38(11):2464\u201373.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"4408_CR6","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1053\/ajkd.2001.27690","volume":"38","author":"O Hotta","year":"2001","unstructured":"Hotta O, Miyazaki M, Furuta T, Tomioka S, Chiba S, Horigome I, Abe K. Taguma Y: Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis. 2001;38(4):736\u201343.","journal-title":"Am J Kidney Dis"},{"key":"4408_CR7","first-page":"94","volume":"157","author":"M Miyazaki","year":"2007","unstructured":"Miyazaki M, Hotta O, Komatsuda A. A multicenter prospective cohort study of tonsillectomy and steroid therapy in Japanese patients with IgA nephropathy: a 5-Year report. Contrib Nephrol. 2007;157:94\u201398.","journal-title":"Contrib Nephrol"},{"issue":"5","key":"4408_CR8","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2215\/CJN.00310108","volume":"3","author":"H Komatsu","year":"2008","unstructured":"Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Kitamura K. Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study. Clin J Am Soc Nephrol. 2008;3(5):1301\u201307.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"4408_CR9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/j.1440-1797.2009.01147.x","volume":"15","author":"T Kawaguchi","year":"2010","unstructured":"Kawaguchi T, Ieiri N, Yamazaki S, Hayashino Y, Gillespie B, Miyazaki M, Taguma Y, Fukuhara S, Hotta O. Clinical effectiveness of steroid pulse therapy combined with tonsillectomy in patients with immunoglobulin A nephropathy presenting glomerular haematuria and minimal proteinuria. Nephrology (Carlton). 2010;15(1):116\u201323.","journal-title":"Nephrology (Carlton)"},{"issue":"6","key":"4408_CR10","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s10157-013-0779-7","volume":"17","author":"K Matsuzaki","year":"2013","unstructured":"Matsuzaki K, Suzuki Y, Nakata J, Sakamoto N, Horikoshi S, Kawamura T, Matsuo S, Tomino Y. Nationwide survey on current treatments for IgA nephropathy in Japan. Clin Exp Nephrol. 2013;17(6):827\u201333.","journal-title":"Clin Exp Nephrol"},{"issue":"12","key":"4408_CR11","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1007\/s10157-023-02396-0","volume":"27","author":"K Matsuzaki","year":"2023","unstructured":"Matsuzaki K, Suzuki H, Kikuchi M, Koike K, Komatsu H, Takahashi K, Narita I, Okada H. Committee of clinical practical guideline for ig AN: current treatment status of IgA nephropathy in Japan: a questionnaire survey. Clin Exp Nephrol. 2023;27(12):1032\u201341.","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"4408_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10157-019-01828-0","volume":"24","author":"S Kumon","year":"2020","unstructured":"Kumon S, Moriyama T, Kamiyama T, Karasawa K, Nitta K. The impact of tonsillectomy combined with steroid pulse therapy in patients with advanced IgA nephropathy and impaired renal function. Clin Exp Nephrol. 2020;24(4):295\u2013306.","journal-title":"Clin Exp Nephrol"},{"key":"4408_CR13","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1093\/ndt\/gfs053","volume":"27","author":"I Maeda","year":"2012","unstructured":"Maeda I, Hayashi T, Sato KK, Shibata MO, Hamada M, Kishida M, Kitabayashi C, Morikawa T, Okada N, Okumura M, et al. Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy. Nephrol Dial Transplant 2012;27:2806\u201313.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"4408_CR14","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3109\/0886022X.2015.1128251","volume":"38","author":"D Yang","year":"2016","unstructured":"Yang D, He L, Peng X, Liu H, Peng Y, Yuan S, Liu Y, Chen X, Liu F, Liu C. The efficacy of tonsillectomy on clinical remission and relapse in patients with IgA nephropathy: a randomized controlled trial. Ren Fail. 2016;38(2):242\u201348.","journal-title":"Ren Fail"},{"issue":"1","key":"4408_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s10157-015-1138-7","volume":"20","author":"H Komatsu","year":"2016","unstructured":"Komatsu H, Sato Y, Miyamoto T, Tamura M, Nakata T, Tomo T, Nishino T, Miyazaki M, Fujimoto S. Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria. Clin Exp Nephrol. 2016;20(1):94\u2013102.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"4408_CR16","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s10157-011-0530-1","volume":"16","author":"N Ieiri","year":"2012","unstructured":"Ieiri N, Hotta O, Sato T. Taguma Y: significance of the duration of nephropathy for achieving clinical remission in patients with IgA nephropathy treated by tonsillectomy and steroid pulse therapy. Clin Exp Nephrol. 2012;16(1):122\u201329.","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"4408_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10157-014-1043-5","volume":"19","author":"N Ieiri","year":"2015","unstructured":"Ieiri N, Osamu H. Importance of the duration of nephropathy prior to tonsillectomy and steroid pulse therapy in IgA nephropathy patients. Clin Exp Nephrol. 2015;19(2):325.","journal-title":"Clin Exp Nephrol"},{"key":"4408_CR18","doi-asserted-by":"crossref","unstructured":"Hirano K, Matsuzaki K, Yasuda T, Nishikawa M, Yasuda Y, Koike K, Maruyama S, Yokoo T, Matsuo S, Kawamura T, et al. Association between tonsillectomy and outcomes in patients with immunoglobulin a nephropathy. JAMA Network Open. 2019;2(5).","DOI":"10.1001\/jamanetworkopen.2019.4772"},{"issue":"4","key":"4408_CR19","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s10157-015-1194-z","volume":"20","author":"J Hoshino","year":"2016","unstructured":"Hoshino J, Fujii T, Usui J, Fujii T, Ohashi K, Takaichi K, Suzuki S, Ubara Y, Yamagata K. Renal outcome after tonsillectomy plus corticosteroid pulse therapy in patients with immunoglobulin A nephropathy: results of a multicenter cohort study. Clin Exp Nephrol. 2016;20(4):618\u201327.","journal-title":"Clin Exp Nephrol"},{"key":"4408_CR20","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/nep.13108","volume":"23","author":"K Matsumoto","year":"2018","unstructured":"Matsumoto K, Ikeda Y, Yamaguchi S, Sanematsu M, Fukuda M, Takashima T, Kishi T, Miyazono M, Uchiumi S, Yoshizaki M, et al. Long-term outcomes of tonsillectomy for IgA nephropathy patients: a retrospective cohort study, two-centre analysis with the inverse probability therapy weighting method. Nephrology (Carlton) 2018;23:846\u201354.","journal-title":"Nephrology (Carlton)"},{"key":"4408_CR21","doi-asserted-by":"publisher","first-page":"18455","DOI":"10.1038\/s41598-023-45514-4","volume":"13","author":"T Kawamura","year":"2023","unstructured":"Kawamura T, Hirano K, Koike K, Nishikawa M, Shimizu A, Joh K, Katafuchi R, Hashiguchi A, Matsuzaki K, Maruyama S, et al. Associations of corticosteroid therapy and tonsillectomy with kidney survival in a multicenter prospective study for IgA nephropathy. Sci Rep 2023;13:18455.","journal-title":"Sci Rep"},{"key":"4408_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000441852","volume":"132","author":"J Feehally","year":"2016","unstructured":"Feehally J, Coppo R, Troyanov S, Bellur SS, Cattran D, Cook T, Roberts IS, Verhave JC, Camilla R, Vergano L, et al. Tonsillectomy in a European cohort of 1,147 patients with IgA nephropathy. Nephron 2016;132:15\u201324.","journal-title":"Nephron"},{"issue":"2","key":"4408_CR23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000100431","volume":"27","author":"Y Chen","year":"2007","unstructured":"Chen Y, Tang Z, Wang Q, Yu Y, Zeng C, Chen H, Liu ZH, Li LS. Long-term efficacy of tonsillectomy in Chinese patients with IgA nephropathy. Am J Nephrol. 2007;27(2):170\u201375.","journal-title":"Am J Nephrol"},{"issue":"8","key":"4408_CR24","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1093\/ndt\/gfq107","volume":"25","author":"A Piccoli","year":"2010","unstructured":"Piccoli A, Codognotto M, Tabbi MG, Favaro E, Rossi B. Influence of tonsillectomy on the progression of mesangioproliferative glomerulonephritis. Nephrol Dial Transplant. 2010;25(8):2583\u201389.","journal-title":"Nephrol Dial Transplant"},{"key":"4408_CR25","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","volume":"100","author":"BH Rovin","year":"2021","unstructured":"Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM, Cook HT, Fervenza FC, Gibson KL, Glassock RJ, et al. Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases. Kidney Int 2021;100:753\u201379.","journal-title":"Kidney Int"},{"issue":"2","key":"4408_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.mayocp.2019.12.004","volume":"95","author":"M Takeuchi","year":"2020","unstructured":"Takeuchi M, Ogura M, Minoura T, Inagaki N, Kawakami K. Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus other classes of glucose-lowering medications on renal outcome in type 2 diabetes. Mayo Clin Proc. 2020;95(2):265\u201373.","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"4408_CR27","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10067-021-05889-z","volume":"41","author":"H Hashimoto","year":"2022","unstructured":"Hashimoto H, Takeuchi M, Kawakami K. Association between biopsies for anti-neutrophil cytoplasmic antibody-associated vasculitis and prognosis: a retrospective cohort study. Clin Rheumatol. 2022;41(2):541\u201348.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"4408_CR28","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/phar.2761","volume":"43","author":"K Ri","year":"2023","unstructured":"Ri K, Fukasawa T, Yoshida S, Takeuchi M, Kawakami K. Risk of parkinsonism and related movement disorders with gabapentinoids or tramadol: a case-crossover study. Pharmacotherapy. 2023;43(2):136\u201344.","journal-title":"Pharmacotherapy"},{"issue":"1","key":"4408_CR29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12882-024-03550-w","volume":"25","author":"A Hayashi","year":"2024","unstructured":"Hayashi A, Mizuno K, Shinkawa K, Sakoda K, Yoshida S, Takeuchi M, Yanagita M, Kawakami K. Effect of multidisciplinary care on diabetic kidney disease: a retrospective cohort study. BMC Nephrol. 2024;25(1):114.","journal-title":"BMC Nephrol"},{"issue":"4","key":"4408_CR30","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/aje\/kwm324","volume":"167","author":"S Suissa","year":"2008","unstructured":"Suissa S. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol. 2008;167(4):492\u201399.","journal-title":"Am J Epidemiol"},{"key":"4408_CR31","doi-asserted-by":"crossref","unstructured":"Dekkers OM, Groenwold RHH. When observational studies can give wrong answers: the potential of immortal time bias. Eur J Endocrinol. 2021;184(1).","DOI":"10.1530\/EJE-20-1124"},{"key":"4408_CR32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.kint.2017.04.019","volume":"92","author":"C Baigent","year":"2017","unstructured":"Baigent C, Herrington WG, Coresh J, Landray MJ, Levin A, Perkovic V, Pfeffer MA, Rossing P, Walsh M, Wanner C, et al. Challenges in conducting clinical trials in nephrology: conclusions from a kidney disease-improving global outcomes (KDIGO) controversies conference. Kidney Int 2017;92:297\u2013305.","journal-title":"Kidney Int"},{"key":"4408_CR33","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"issue":"28","key":"4408_CR34","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661\u201379.","journal-title":"Stat Med"},{"key":"4408_CR35","doi-asserted-by":"crossref","unstructured":"Stuart EA, Lee BK, Leacy FP. Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research. J Clin Epidemiol. 2013;66 (8 Suppl):S84-S90 e81.","DOI":"10.1016\/j.jclinepi.2013.01.013"},{"key":"4408_CR36","doi-asserted-by":"crossref","unstructured":"Yu D, Qu B, Osuagwu UL, Pickering K, Baker J, Cutfield R, Cai Y, Orr-Walker BJ, Sundborn G, Zhao Z, et al. Association between onset of type 2 diabetes and risk of atrial fibrillation in new zealanders with impaired glucose tolerance over 25 years. J Am Heart Assoc. 2023;12(18).","DOI":"10.1161\/JAHA.123.030159"},{"issue":"1","key":"4408_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11255-016-1432-7","volume":"49","author":"J Duan","year":"2017","unstructured":"Duan J, Liu D, Duan G, Liu Z. Long-term efficacy of tonsillectomy as a treatment in patients with IgA nephropathy: a meta-analysis. Int Urol Nephrol. 2017;49(1):103\u201312.","journal-title":"Int Urol Nephrol"},{"key":"4408_CR38","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s10157-009-0179-1","volume":"13","author":"N Miura","year":"2009","unstructured":"Miura N, Imai H, Kikuchi S, Hayashi S, Endoh M, Kawamura T, Tomino Y, Moriwaki K, Kiyomoto H, Kohagura K, et al. Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapy. Clin Exp Nephrol 2009;13:460\u201366.","journal-title":"Clin Exp Nephrol"},{"key":"4408_CR39","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s10157-021-02095-8","volume":"25","author":"H Suzuki","year":"2021","unstructured":"Suzuki H, Kikuchi M, Koike K, Komatsu H, Matsuzaki K, Takahashi K, Ichikawa D, Okabe M, Obata Y, Katafuchi R, et al. A digest from evidence-based clinical practice guideline for IgA nephropathy 2020. Clin Exp Nephrol 2021;25:1269\u201376.","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"4408_CR40","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2215\/CJN.01990213","volume":"9","author":"X Li","year":"2014","unstructured":"Li X, Liu Y, Lv J, Shi S, Liu L, Chen Y, Zhang H. Progression of IgA nephropathy under current therapy regimen in a Chinese population. Clin J Am Soc Nephrol. 2014;9(3):484\u201389.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"4408_CR41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12882-025-03958-y","volume":"26","author":"M Rivedal","year":"2025","unstructured":"Rivedal M, Nordb\u00f8 OP, Haaskjold YL, Bj\u00f8rneklett R, Knoop T, \u00d8 E. Lifetime progression of IgA nephropathy: a retrospective cohort study with extended long-term follow-up. BMC Nephrol. 2025;26(1):32.","journal-title":"BMC Nephrol"},{"key":"4408_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1440-1797.2010.01309.x","volume":"15","author":"N Chen","year":"2010","unstructured":"Chen N, Hsu CC, Yamagata K, Langham R. Challenging chronic kidney disease: experience from chronic kidney disease prevention programs in Shanghai, Japan, Taiwan and Australia. Nephrology (Carlton). 2010;15:31\u201336. Suppl 2.","journal-title":"Nephrology (Carlton)"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04408-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04408-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04408-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T20:24:55Z","timestamp":1757449495000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04408-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4408"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04408-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,23]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Kyoto University and Graduate School and Faculty of Medicine, Ethics Committee (R3714) and did not require individual consent because the data were anonymized. This study adhered to the principles of the Declaration of Helsinki. The need for informed consent was waived by Kyoto University and Graduate School and Faculty of Medicine, Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"K.M has been employed by the Department of Digital Health and Epidemiology with support from Eisai Co., Ltd. and Kyowa Kirin Co., Ltd and received grants from Japan Society for the Promotion of Science. S.Y has received consulting fees from TOYOTA Konpon Research Institute Inc. M.Y received research funds from Mitsubishi Tanabe Pharma and Boehringer Ingelheim. K. K has received research funds from AstraZeneca K.K., Eisai Co., Ltd., Kyowa Kirin Co., Ltd., Mitsubishi Corporation, OMRON Corporation, Real World Data Co., Ltd., Sumitomo Pharma Co., Ltd., and Toppan Inc.; consulting fees from Advanced Medical Care Inc., JMDC Inc., LEBER Inc., Ubicom Holdings, Inc., Santen Pharmaceutical Co., Ltd., and Shin Nippon Biomedical Laboratories Ltd.; executive compensation from Cancer Intelligence Care Systems, Inc.; honoraria from Kaken Pharmaceutical Co., Ltd., Kyoto University Original Co., Ltd., Pharma Business Academy, Shionogi & Co., Ltd., Taisho Pharmaceutical Co., Ltd., and Toppan Inc.; and held stock in Real World Data Co., Ltd. All other authors have no completing interest to declare' in the completing interest statement.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"484"}}